AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 157 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2016. The put-call ratio across all filers is 1.22 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $5,784,000 | -61.4% | 75,000 | -57.9% | 0.21% | -65.9% |
| Q2 2018 | $14,993,000 | +3.0% | 178,000 | 0.0% | 0.62% | -8.8% |
| Q1 2018 | $14,557,000 | +19.0% | 178,000 | -16.8% | 0.68% | +6.9% |
| Q4 2017 | $12,234,000 | -14.4% | 214,000 | 0.0% | 0.64% | -21.2% |
| Q3 2017 | $14,285,000 | -7.7% | 214,000 | -28.9% | 0.81% | -16.0% |
| Q2 2017 | $15,476,000 | -11.9% | 300,800 | 0.0% | 0.96% | -17.1% |
| Q1 2017 | $17,567,000 | +40.0% | 300,800 | 0.0% | 1.16% | +42.4% |
| Q4 2016 | $12,552,000 | -21.0% | 300,800 | 0.0% | 0.82% | -15.8% |
| Q3 2016 | $15,888,000 | +26.1% | 300,800 | 0.0% | 0.97% | +25.8% |
| Q2 2016 | $12,602,000 | +3.2% | 300,800 | 0.0% | 0.77% | +13.0% |
| Q1 2016 | $12,212,000 | -37.5% | 300,800 | 0.0% | 0.68% | -30.1% |
| Q4 2015 | $19,528,000 | +13.0% | 300,800 | +22.8% | 0.98% | -2.8% |
| Q3 2015 | $17,287,000 | -6.4% | 244,900 | +47.4% | 1.00% | +0.5% |
| Q2 2015 | $18,471,000 | +17.9% | 166,200 | 0.0% | 1.00% | -15.3% |
| Q1 2015 | $15,673,000 | -45.8% | 166,200 | -35.6% | 1.18% | -62.7% |
| Q4 2014 | $28,929,000 | +9.3% | 258,200 | -40.2% | 3.16% | -14.6% |
| Q3 2014 | $26,479,000 | +17.8% | 431,600 | -12.0% | 3.70% | +21.0% |
| Q2 2014 | $22,475,000 | +26.4% | 490,500 | +8.0% | 3.06% | +10.7% |
| Q1 2014 | $17,782,000 | +255.6% | 454,200 | +117.5% | 2.76% | +79.1% |
| Q4 2013 | $5,001,000 | – | 208,800 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Eagle Health Investments LP | 431,413 | $12,558,000 | 3.09% |
| Casdin Capital, LLC | 2,090,000 | $60,840,000 | 2.73% |
| Rock Springs Capital Management LP | 2,665,275 | $77,586,000 | 1.95% |
| Bellevue Group AG | 4,129,292 | $120,204,000 | 1.40% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 1,177,374 | $34,273,000 | 1.05% |
| Altium Capital Management LP | 66,196 | $1,927,000 | 0.64% |
| ArrowMark Colorado Holdings LLC | 1,295,948 | $37,725,000 | 0.33% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,333,012 | $38,804,000 | 0.19% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 21,500 | $707,000 | 0.16% |
| Virtus ETF Advisers LLC | 11,541 | $336,000 | 0.15% |